Related Experiment Videos
Chemokines: progress toward identifying molecular targets for therapeutic agents
O M Howard1, A Ben-Baruch, J J Oppenheim
1SAIC Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, MD 21702-1201, USA.
Trends in Biotechnology
|February 1, 1996
Summary
Chemokines guide leukocyte movement to injury sites, playing roles in inflammation and immunity. Understanding chemokine structure and function aids in developing new therapeutic antagonists.
Area of Science:
- Immunology
- Molecular Biology
- Pharmacology
Background:
- Leukocyte migration is crucial for immune responses and tissue repair.
- Chemokines and their receptors orchestrate leukocyte trafficking.
- Dysregulated chemokine activity is implicated in various inflammatory diseases, cancer, and angiogenesis.
Purpose of the Study:
- To review advances in chemokine structure and function.
- To highlight the pathophysiological roles of chemokines in disease.
- To discuss the development of chemokine antagonists as potential therapeutics.
Main Methods:
- Review of current literature on chemokine structure and function.
- Analysis of chemokine roles in viral, bacterial, parasitic infections, allergic reactions, atherosclerosis, arthritis, tumor immunity, and angiogenesis.
- Examination of tertiary structures and mutational analysis for drug design.
Main Results:
- Chemokines are key regulators of leukocyte adhesion, diapedesis, and homing.
- Chemokines contribute to diverse inflammatory conditions and have roles in tumor immunity and angiogenesis.
- Knowledge of chemokine-receptor interactions is enabling the rational design of antagonists.
Conclusions:
- Chemokines are critical mediators in immunity and inflammation.
- Targeting chemokine pathways offers therapeutic potential for various diseases.
- Further research into chemokine structure-function relationships will drive the development of novel anti-inflammatory and anti-cancer agents.